ACHE and neoplasm: In general, the aforementioned findings demonstrated that it is reasonable to declare that solasonine, as an ACHE inhibitor, would be effective for tumor treatment through the regulation of cell apoptosis and inflammation by p38 MAPK pathway (Fig. 7).